Context: Thyroid function testing often uses thyrotropin (TSH) measurement first, followed by reflex testing for free thyroxine (T4) if TSH is outside the reference range. The utility of different TSH cutoffs for reflex testing is unknown.
T he laboratory diagnosis of thyroid dysfunction relies on measurement of circulating concentrations of thyrotropin (TSH), free thyroxine (T4), and, in some cases, free triiodothyronine. TSH and free T4 have a complex, nonlinear relationship, such that small changes in free T4 result in relatively large changes in TSH (1) . Thus, TSH measurement is a sensitive screening test for thyroid dysfunction, and it is considered the most useful initial test of thyroid function for the vast majority of patients (2) (3) (4) . Evidence for this includes a study by de los Santos et al. (5) , which showed TSH had greater sensitivity and specificity than T4 or triiodothyronine for detecting thyroid dysfunction, and a retrospective study by Bauer and Brown (6) , which found that measurement of free T4 did not contribute to patient management when TSH was within the reference range. Furthermore, a quality and cost analysis by Nordyke et al. (7) found that the initial measurement of TSH, followed by measurement of free T4 if the TSH level was abnormal, was preferable to the reverse sequence. Guidelines from the American Thyroid Association (8, 9) , American Association of Clinical Endocrinologists (10) , and National Academy of Clinical Biochemistry (11) have all endorsed measurement of TSH as the best first-line strategy for detecting thyroid dysfunction in most clinical settings. It has, however, been recognized that measurement of TSH alone is not reliable for the detection of central hypothyroidism and can be misleading in other clinical settings, including treated hyperthyroidism and nonthyroidal illness.
In line with these recommendations, many laboratories will measure only TSH in the initial assessment of thyroid function, except in particular clinical circumstances (including known or suspected pituitary disease and treated thyroid disease). Additional measurement of free T4 is performed only if the TSH is outside the reference range (12) , an example of "reflex" testing, whereby an additional test is added automatically in the laboratory according to defined algorithms (13) . The rationale for such reflex testing is that free T4 is measured only when a reasonable likelihood exists of an abnormal result (as indicated by the TSH level). This reduces the need for free T4 testing without compromising the detection of overt thyroid dysfunction and is thus costeffective.
The TSH reference range has itself been the subject of controversy (14, 15) . In the early 2000s, several authorities argued that the upper limit of the reference range should be reduced to 2.5 or 3.0 mU/L (11). In contrast, more recently, studies have supported increasing the reference range upper limit for older individuals (14, 16, 17) . Such changes will affect the number of samples for which reflex testing for free T4 is performed. Most laboratories now report a reference range upper limit of 4.0 to 5.5 mU/L for TSH, and some have adopted agerelated reference ranges. In overt hypothyroidism, TSH is expected to be .10 mU/L (11). Thus, reflex testing of free T4 when the TSH level is 4 to 10 mU/L might not be necessary, because the likelihood of finding a reduced free T4 is low. At the other end of the TSH reference range, most laboratories report a reference range lower limit of 0.4 to 0.5 mU/L. In overt hyperthyroidism, TSH is expected to be suppressed to ,0.1 mU/L (some definitions of overt hyperthyroidism require this) (18) ; therefore, reflex testing of free T4 when the TSH level is 0.1 to 0.4 mU/L might be unnecessary. Although thyroid function tests are among the most commonly requested laboratory analytes and reflex testing for free T4 is widespread, to the best of our knowledge, no detailed studies have examined the utility of different TSH cutoffs for reflex testing, and only very limited data are available (13) .
Therefore, the aim of the present study was to examine whether TSH cutoffs outside conventional reference range limits can further reduce the need for reflex testing of free T4 and preserve sensitivity for detecting overt hypothyroidism and hyperthyroidism.
Materials and Methods
We analyzed all thyroid function tests with concurrent TSH and free T4 results obtained using a single method during a 12-year period from a single private pathology laboratory providing statewide services across Western Australia, which is an iodine-sufficient area (19) with a mainly white population. Details of the data set, laboratory methods, and quality control have been previously reported (1) . In brief, serum TSH and free T4 concentrations were measured using an ADVIA Centaur analyzer (Siemens Ltd, North Ryde, NSW, Australia). The TSH assay does not use biotin; the free T4 assay uses a preformed, stable biotin-streptavidin complex that is not affected by exogenous biotin. The laboratory reference ranges (derived from data extraction and consensus between local chemical pathologists and endocrinologists) were 0.4 to 4.0 mU/L for TSH and 10 to 20 pmol/L for free T4. The free T4 concentrations are reported as whole numbers in pmol/L (to convert to ng/dL, multiply by 0.078). The results were de-identified before analysis. Because the study fit the criteria of an audit, institutional ethics approval and informed consent were not required.
In Australia, TSH testing is reimbursed through a national Medicare program without restriction. However, reimbursement for concurrent TSH and free T4 testing is provided only for specific indications, including a previously abnormal TSH result, known thyroid disease, dementia or psychiatric illness, amenorrhea or infertility, suspected pituitary dysfunction, and the use of drugs that interfere with thyroid hormone metabolism or function (20) . The participants in the present study therefore had satisfied one or more of these criteria to have concurrent measurements of TSH and free T4 available.
The initial data set contained 525,713 records. As previously described (1), we used clinical information from request forms and laboratory records dating back to 1985 to exclude 79,719 records from individuals with factors that could potentially confound physiological hypothalamic-pituitary-thyroid axis function or result in analytical interference with thyroid function testing, including hospitalized patients, pregnant women, infants, patients receiving specialist endocrine care, samples collected outside office hours, and patients treated with lithium carbonate, anticonvulsant agents, or amiodarone. We also excluded patients with hypothalamic-pituitary-thyroid axis disorders, including treated thyrotoxicosis, treatment with radioiodine, antithyroid drugs or liothyronine, thyroid surgery, and hypopituitarism. The remaining data set comprised 445,994 records from 152,261 subjects. The first record for each individual was retained, and subsequent records were excluded. For the present study, we further excluded 31,858 subjects with a laboratory record of T4 therapy at any time, resulting in a final data set of 120,403 subjects (referred to as the clinical cohort). After these exclusions, the remaining patients would mostly have qualified for concurrent TSH and free T4 testing on the basis of having a previous abnormal TSH result.
To explore the effect of different TSH cutoffs for reflex free T4 testing, the counts and percentages of the subjects with high or low free T4 at different parts of the TSH value range were calculated. Using receiver operating characteristic (ROC) curve analysis, the sensitivity and specificity of TSH for detecting high free T4 (.20 pmol/L) and low free T4 (,10 pmol/L) were established for values across the TSH range.
To examine the effects of different TSH cutoffs for reflex testing of free T4 on screening for thyroid disease in a community setting, we analyzed the data from 4568 participants in the 1994 Busselton Health Study, who were not taking T4 (referred to as the community cohort). Details of the Busselton Health Study and the participants have been previously reported (21) . In brief, Busselton is a rural town in Western Australia that has been the site of a series of cross-sectional health surveys. Archived sera from the 1994 survey were analyzed for TSH and free T4 in three runs in 2007, 2011, and 2013 (one sample per patient) using an Immulite 2000 chemiluminescent analyzer (Siemens Ltd., North Ryde, NSW, Australia), as previously described (22) . The reference ranges (based on the 2.5 and 97.5 percentiles of thyroid peroxidase antibody-negative participants) were as follows: TSH, 0.4 to 4.0 mU/L; and free T4, 11.5 to 20.8 pmol/L.
Analyses were performed in the R statistical computing environment, version 3.3.1 (23) .
Results

Demographic data
After the exclusions, the clinical cohort comprised 120,403 individuals with no recorded history of thyroid hormone treatment. Most participants were female (72%), with a mean age of 50.6 6 19.3 years. As expected for a population with an indication for concurrent measurement of free T4 and TSH (and a high prevalence of thyroid dysfunction), the median TSH concentration was in the upper part of the reference range at 3.5 mU/L (lower quartile, 1.2; upper quartile, 4.9). For 45.2% of the individuals, the TSH level was within the reference range.
Frequency of low and high free T4 values
Of the 120,403 subjects, the TSH level was less than the reference range in 13.1% and elevated in 41.7%. In contrast, free T4 was ,10 pmol/L in 4.6% and .20 pmol/L in 2.3% of the individuals (Table 1) . Of the subjects with TSH within the reference range (0.4 to 4.0 mU/L), 1.8% had a low free T4. In 86% of these latter subjects, the free T4 level was either 8 or 9 pmol/L (just less than the reference range), suggesting that most individuals could have been healthy outliers. Free T4 was elevated in 1.2% of subjects whose TSH was within the reference range. In 71% of these latter subjects, the free T4 level was 21 to 23 pmol/L (just greater than the reference range). Of the subjects with a low TSH level (,0.4 mU/L), free T4 was elevated in 12.3%. In contrast, of those with an elevated TSH (.4.0 mU/L), 8.8% had a low free T4. In addition, 194 participants (0.16%) had elevated TSH and elevated free T4 levels, and 189 (0.16%) had low TSH and low free T4 levels.
Frequency of high or low free T4 at different TSH levels
The frequency of high free T4 concentrations (.20 pmol/L) at different TSH levels is shown graphically in Fig. 1A , with TSH plotted as bins. Moving from the upper to lower part of the TSH reference range, a gradual increase occurred in the frequency of elevated free T4, from 0.5% of subjects with TSH levels of 3.0 to 4.0 mU/L to 2.1% of those with TSH levels of 0.4 to 1.0 mU/L. An apparent inflection in the curve was seen at~0.3 mU/L, with high free T4 levels present in 3.4% of individuals with TSH levels of 0.3 to 0.4 mU/L and 5.3% for TSH levels of 0.2 to 0.3 mU/L. At lower TSH levels, the frequency of high free T4 increased further, to #48.2% of those with undetectable TSH levels (#0.01 mU/L).
The frequency of low free T4 concentrations (,10 pmol/L) at different TSH levels is shown in Fig. 1B . Moving from the lower to the upper part of the TSH reference range, a very gradual increase in frequency of low free T4 is evident, from 1.3% of individuals with TSH levels of 0.4 to 1.0 mU/L to 2.0% for TSH levels of 3.0 to 4.0 mU/L. An apparent inflection in the curve was seen at~5.0 mU/L, with the frequency of low free T4 increasing from 2.2% for TSH levels of 4.0 to 5.0 mU/L to 3.1% for TSH levels of 5.0 to 6.0 mU/L. At higher TSH levels, the frequency of low free T4 increased further, to 14.5% in subjects with TSH levels 10.0 to 14.0 mU/L and 69.3% for TSH levels .20 mU/L.
ROC curve analysis
The sensitivity and specificity of TSH for detecting high free T4 (.20 pmol/L) are shown in Supplemental Fig. 1 . The minimum ROC distance criterion for detecting a high free T4 resulted in a TSH cutoff of 0.69 mU/L, with 83% specificity and 76% sensitivity. A specificity of 90% was achieved at a TSH cutoff of 0.36 mU/L and 95% at 0.22 mU/L. For the detection of low free T4 (,10 pmol/L), the minimum ROC distance criterion resulted in a TSH cutoff of 5.15 mU/L, with 80% specificity and 69% sensitivity. A specificity of 90% was observed with a TSH cutoff of 6.6 mU/L and 95% specificity at 8.6 mU/L.
Effect of changes to lower and upper thresholds
The frequency of high or low free T4 values for selected bins of TSH was determined to explore the effect of different TSH cutoffs for reflex testing of free T4 (Table 2) . Reducing the lower TSH cutoff for reflex testing from 0.4 mU/L (lower limit of the reference range) to 0.3 mU/L would have eliminated free T4 testing for 4.3% of the cohort and result in elevated free T4 remaining undetected in 176 subjects (0.15% of the cohort). In these latter individuals, however, free T4 was minimally elevated (21 to 23 pmol/L) in 76% (a frequency similar to those with TSH levels in the reference range, 71%), and probably did not indicate clinically relevant hyperthyroidism. Moving the TSH cutoff further to 0.2 mU/L would have eliminated free T4 testing for a further 3.3% of the cohort and would have failed to detect elevated free T4 levels in a further 209 individuals (0.17% of the cohort). In these latter participants, the free T4 level was 21 to 23 pmol/L in 76%.
At the upper end of the TSH reference range, increasing the TSH cutoff for reflex testing from 4.0 to 5.0 mU/L would have eliminated free T4 testing for 17.9% of the cohort and would have failed to detect low free T4 in 475 individuals (0.39% of the cohort). In most of these latter individuals, free T4 was only mildly reduced (9 pmol/L in 77.3% and 8 pmol/L in 16.4%). Increasing the TSH cutoff further to 6.0 mU/L would have eliminated free T4 testing for a further 8.5% of the cohort and would have failed to detect reduced free T4 levels in a further 313 individuals (0.26% of the cohort). Of the latter group, the free T4 level was 8 or 9 pmol/L in 93.6%.
Reductions in free T4 testing in clinical and community cohorts
The reductions in the number of individuals undergoing testing for free T4 when different TSH cutoffs for reflex testing are applied alone or in combination to the clinical cohort are listed in Table 3 . Applying the TSH cutoffs of 0.3 and 5.0 mU/L eliminated free T4 testing for 22.2% of those referred for testing. In contrast, cutoffs of 0.2 and 6.0 mU/L eliminated free T4 testing for 34.0%. The effects of different TSH cutoffs for reflex testing on screening for thyroid disease in a community setting, using data from 4568 participants in the Busselton Health Study who were not taking T4 are also listed in Table 3 . The TSH level was within the reference range in 4211 participants (92.2%). In this community cohort, applying TSH cutoffs of 0.30 and 5.0 mU/L eliminated the need for free T4 testing in 3.3% of individuals. In contrast, applying cutoffs of 0.2 and 6.0 mU/L would have avoided free T4 testing in 4.8% of the participants. Table 4 shows the diagnostic yield of free T4 measurements when different TSH cutoffs for reflex testing are applied to the clinical cohort. If the TSH cutoff were reduced from 0.4 to 0.3 mU/L, the proportion of subjects with low TSH levels and high free T4 would increase from 12.3% to 16.7%. Reducing the cutoff to 0.2 mU/L increased the proportion further to 23.3%. At the upper end of the TSH range, increasing the cutoff for reflex testing from 4.0 to 5.0 mU/L increased the proportion of individuals with high TSH levels and low free T4 levels from 8.8% to 13.7%, whereas a cutoff of 6.0 mU/L increased it further to 19.7%.
Discussion
To the best of our knowledge, the present study is the first detailed analysis of the effect of different TSH cutoffs for reflex testing of free T4, a widespread laboratory practice. Our results have shown that in a clinical cohort of subjects referred for thyroid function testing, the use of wider TSH cutoffs to trigger reflex testing results in a substantial reduction in the need for free T4 testing compared with when the TSH reference range limits are used (the current approach). Specifically, applying TSH cutoffs of 0.3 and 5.0 mU/L for reflex testing in place of the reference range limits of 0.4 and 4.0 mU/L resulted in a 22% reduction in free T4 tests, whereas cutoffs of 0.2 and 6.0 mU/L reduced free T4 testing by 34%. This reduction in free T4 testing is in addition to the 45% of individuals who would not undergo free T4 testing using the current approach because the TSH level was within the reference range. The effect of these TSH cutoffs in the community cohort was smaller, with corresponding reductions in free T4 testing of 3.2% and 4.8%, reflecting the lower prevalence of thyroid dysfunction in the general community (with TSH levels within the reference range in 92%) compared with that in patients referred for testing. In both settings, the reduced need for free T4 testing has the potential to reduce costs and improve cost-effectiveness.
An important consideration is whether this approach would result in cases of overt hypothyroidism and Data are shown as number of subjects and (cumulative) percentage with high free T4 concentrations and TSH less than specified cutoffs; and low free T4 concentrations with TSH greater than specified cutoffs.
hyperthyroidism remaining undetected. However, our data suggest that the effect would be minimal. In the clinical cohort, free T4 was greater than the reference range in 4.2% of those subjects whose TSH level was 0.2 to 0.4 mU/L. However, in most of these subjects (76%), the free T4 level was only marginally elevated. Some of these patients might have been taking T4 treatment, which was not known to the laboratory. It is unlikely that these individuals had clinically relevant hyperthyroidism [some definitions of overt hyperthyroidism require the TSH level to be suppressed to ,0.1 mU/L (18)], and it is equally unlikely that not measuring free T4 would adversely affect patient care. This is consistent with data from Ross et al. (24) , who concluded that for most patients, free T4 measurement altered management only when the TSH level was ,0.05 mU/L. Similarly, although free T4 was less than the reference range in 2.5% of individuals whose TSH was 4 to 6 mU/L, in almost all (94%) of these, free T4 was only marginally reduced. It is doubtful that these individuals had clinically relevant hypothyroidism and could have included healthy outliers whose free T4 value lies just outside the reference range, with nonspecific elevations in TSH associated with age or nonthyroidal illness. It is also possible that some had clinically unsuspected hypopituitarism, although this is uncommon. Because the reference range for free T4 is expected to include 95% of the healthy population, it was not surprising to detect a number of individuals with slightly increased or reduced free T4 concentrations that are not clinically important. Evidence is lacking regarding the clinical implications of thyroid function tests just outside the reference range; however, from first principles, it is likely to be clinically unimportant in most cases.
Thyroid function tests are among the most commonly requested pathology tests in primary care, and the volume of "routine" testing has been increasing (25) (26) (27) (28) . In Australia, which has a population of 24 million, .7 million thyroid function tests were billed to Medicare from July 2015 to June 2016, of which, 2.4 million included concurrent free T4 testing (29) . The estimated cost savings achieved in Australia by reducing the number of free T4 tests by 22% to 34% would be AUD $4.5 to AUD $7 million annually (US $3.5 to US $5.4 million). Cost savings elsewhere will vary depending on the TSH reference ranges in use and local funding arrangements; however, because health care systems worldwide are under pressure to achieve greater efficiency and costeffectiveness, our results should be generally applicable.
The strengths of our study included the large size and broad referral base of the clinical cohort, which is likely to be generally representative of clinical laboratory data sets in other Western countries. A further strength was that we explored the effect of different TSH cutoffs in an independent, well-characterized community cohort to model the effects on thyroid screening in primary care. The principal limitation of our study was that for the clinical cohort, clinical information was limited to that available from the pathology request forms and laboratory records. Although we excluded patients with a record of T4 treatment or other factors potentially affecting thyroid function test results, it is possible that some of these individuals might have been included. The inadvertent inclusion of some T4-treated individuals could have accounted for some of the individuals with slightly reduced TSH levels and elevated free T4 levels. Our analysis was based on two TSH methods with a common reference range. The TSH cutoffs we used might not apply to other TSH immunoassays, because intermethod differences of #1 mU/L at concentrations of 4 to 5 mU/L have been reported (16) . Nevertheless, it is likely that for other TSH methods, setting TSH cutoffs 0.1 to 0.2 mU/L less than the reference range lower limit and 1 to 2 mU/L greater than the reference range upper limit would give similar results. It is important to stress that although this approach is appropriate for most samples received by clinical laboratories, a TSH-alone approach is not appropriate for certain patient groups, including those with known or suspected pituitary disease and those with established thyroid disease.
In conclusion, the results of the present study have shown that applying wider TSH cutoffs for reflex testing of free T4 than the currently used TSH reference range limits can substantially reduce the number of free T4 tests performed, with minimal effects on case detection of overt hyperthyroidism and hypothyroidism.
